Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
PHASE2
The goal of this study is to learn the efficacy and safety of nimotuzumab c...
Status
Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medcial Science and Peking Union Medical College
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
PHASE2
The purpose of this study is to explore the efficacy and safety of a combin...
Status
Unknown
Location
Department of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital
Efficacy and Safety of TPC Induction Chemotherapy Combined With Nimotuzumab and Toripalimab "Immune Sandwich" Regimen Versus Full-Course Immunotherapy for Locally Advanced Nasopharyngeal Carcinoma
PHASE3
Immunotherapy combined with chemoradiotherapy has become standard care for ...
Status
Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University